CT of Post-Acute Lung Complications of COVID-19

Overview

Journal Radiology

Specialty Radiology

Date 2021 Aug 10

PMID 34374591

Citations 80

Authors

Joshua J Solomon

Brooke Heyman

Jane P Ko

Rany Condos

David A Lynch

Affiliations

Soon will be listed here.

Abstract

The acute course of COVID-19 is variable and ranges from asymptomatic infection to fulminant respiratory failure. Patients recovering from COVID-19 can have persistent symptoms and CT abnormalities of variable severity. At 3 months after acute infection, a subset of patients will have CT abnormalities that include ground-glass opacity (GGO) and subpleural bands with concomitant pulmonary function abnormalities. At 6 months after acute infection, some patients have persistent CT changes to include the resolution of GGOs seen in the early recovery phase and the persistence or development of changes suggestive of fibrosis, such as reticulation with or without parenchymal distortion. The etiology of lung disease after COVID-19 may be a sequela of prolonged mechanical ventilation, COVID-19-induced acute respiratory distress syndrome (ARDS), or direct injury from the virus. Predictors of lung disease after COVID-19 include need for intensive care unit admission, mechanical ventilation, higher inflammatory markers, longer hospital stay, and a diagnosis of ARDS. Treatments of lung disease after COVID-19 are being investigated, including the potential of antifibrotic agents for prevention of lung fibrosis after COVID-19. Future research is needed to determine the long-term persistence of lung disease after COVID-19, its impact on patients, and methods to either prevent or treat it. © RSNA, 2021.

Citing Articles

Serum Lactate Dehydrogenase Levels Reflect the Lung Injury Extension in COVID-19 Patients at Hospital Admission.

Bertilacchi M, Vannucci G, Piccarducci R, Germelli L, Giacomelli C, Romei C Immun Inflamm Dis. 2025; 13(3):e70168.

PMID: 40071734 PMC: 11898011. DOI: 10.1002/iid3.70168.

Long-Term Pulmonary Sequelae and Immunological Markers in Patients Recovering from Severe and Critical COVID-19 Pneumonia: A Comprehensive Follow-Up Study.

Strumiliene E, Urboniene J, Jurgauskiene L, Zeleckiene I, Bliudzius R, Malinauskiene L Medicina (Kaunas). 2025; 60(12.

PMID: 39768836 PMC: 11678914. DOI: 10.3390/medicina60121954.

Machine learning predicts pulmonary Long Covid sequelae using clinical data.

Cordelli E, Soda P, Citter S, Schiavon E, Salvatore C, Fazzini D BMC Med Inform Decis Mak. 2024; 24(1):359.

PMID: 39604988 PMC: 11600907. DOI: 10.1186/s12911-024-02745-3.

Early pulmonary fibrosis-like changes between delta and pre-delta periods in patients with severe COVID-19 pneumonia on mechanical ventilation.

Yoo J, Kim W, Chung C, Cho Y, Lee J, Jegal Y Sci Rep. 2024; 14(1):26101.

PMID: 39478105 PMC: 11525473. DOI: 10.1038/s41598-024-77405-7.

Predicting malignant potential of solitary pulmonary nodules in patients with COVID-19 infection: a comprehensive analysis of CT imaging and tumor markers.

Xiao H, Liu Y, Liang P, Hou P, Zhang Y, Gao J BMC Infect Dis. 2024; 24(1):1050.

PMID: 39333962 PMC: 11430562. DOI: 10.1186/s12879-024-09952-3.

References

Cabrera-Benitez N, Laffey J, Parotto M, Spieth P, Villar J, Zhang H . Mechanical ventilation-associated lung fibrosis in acute respiratory distress syndrome: a significant contributor to poor outcome. Anesthesiology. 2014; 121(1):189-98. PMC: 4991945. DOI: 10.1097/ALN.0000000000000264. View

Grillo F, Barisione E, Ball L, Mastracci L, Fiocca R . Lung fibrosis: an undervalued finding in COVID-19 pathological series. Lancet Infect Dis. 2020; 21(4):e72. PMC: 7386839. DOI: 10.1016/S1473-3099(20)30582-X. View

Richeldi L, du Bois R, Raghu G, Azuma A, Brown K, Costabel U . Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis. N Engl J Med. 2014; 370(22):2071-82. DOI: 10.1056/NEJMoa1402584. View

Lauer S, Grantz K, Bi Q, Jones F, Zheng Q, Meredith H . The Incubation Period of Coronavirus Disease 2019 (COVID-19) From Publicly Reported Confirmed Cases: Estimation and Application. Ann Intern Med. 2020; 172(9):577-582. PMC: 7081172. DOI: 10.7326/M20-0504. View

Chang R, Elhusseiny K, Yeh Y, Sun W . COVID-19 ICU and mechanical ventilation patient characteristics and outcomes-A systematic review and meta-analysis. PLoS One. 2021; 16(2):e0246318. PMC: 7877631. DOI: 10.1371/journal.pone.0246318. View

Li K, Liu X, Yip R, Yankelevitz D, Henschke C, Geng Y . Early prediction of severity in coronavirus disease (COVID-19) using quantitative CT imaging. Clin Imaging. 2021; 78:223-229. PMC: 7874917. DOI: 10.1016/j.clinimag.2021.02.003. View

Wu Z, McGoogan J . Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. JAMA. 2020; 323(13):1239-1242. DOI: 10.1001/jama.2020.2648. View

Dhawan R, Gopalan D, Howard L, Vicente A, Park M, Manalan K . Beyond the clot: perfusion imaging of the pulmonary vasculature after COVID-19. Lancet Respir Med. 2020; 9(1):107-116. PMC: 7833494. DOI: 10.1016/S2213-2600(20)30407-0. View

Stadler K, Masignani V, Eickmann M, Becker S, Abrignani S, Klenk H . SARS--beginning to understand a new virus. Nat Rev Microbiol. 2004; 1(3):209-18. PMC: 7097337. DOI: 10.1038/nrmicro775. View

10.

Hwang D, Chamberlain D, Poutanen S, Low D, Asa S, Butany J . Pulmonary pathology of severe acute respiratory syndrome in Toronto. Mod Pathol. 2004; 18(1):1-10. PMC: 7100506. DOI: 10.1038/modpathol.3800247. View

11.

Mackey K, Ayers C, Kondo K, Saha S, Advani S, Young S . Racial and Ethnic Disparities in COVID-19-Related Infections, Hospitalizations, and Deaths : A Systematic Review. Ann Intern Med. 2020; 174(3):362-373. PMC: 7772883. DOI: 10.7326/M20-6306. View

12.

Horby P, Lim W, Emberson J, Mafham M, Bell J, Linsell L . Dexamethasone in Hospitalized Patients with Covid-19. N Engl J Med. 2020; 384(8):693-704. PMC: 7383595. DOI: 10.1056/NEJMoa2021436. View

13.

Wang Y, Luo H, Liu S, Huang S, Zhou Z, Yu Q . Dynamic evolution of COVID-19 on chest computed tomography: experience from Jiangsu Province of China. Eur Radiol. 2020; 30(11):6194-6203. PMC: 7283983. DOI: 10.1007/s00330-020-06976-6. View

14.

Davidson T, Caldwell E, Curtis J, Hudson L, Steinberg K . Reduced quality of life in survivors of acute respiratory distress syndrome compared with critically ill control patients. JAMA. 1999; 281(4):354-60. DOI: 10.1001/jama.281.4.354. View

15.

Chen H, Xie J, Su N, Wang J, Sun Q, Li S . Corticosteroid Therapy Is Associated With Improved Outcome in Critically Ill Patients With COVID-19 With Hyperinflammatory Phenotype. Chest. 2020; 159(5):1793-1802. PMC: 7834518. DOI: 10.1016/j.chest.2020.11.050. View

16.

Wang C, Horby P, Hayden F, Gao G . A novel coronavirus outbreak of global health concern. Lancet. 2020; 395(10223):470-473. PMC: 7135038. DOI: 10.1016/S0140-6736(20)30185-9. View

17.

Lieveld A, Azijli K, Teunissen B, van Haaften R, Kootte R, van den Berk I . Chest CT in COVID-19 at the ED: Validation of the COVID-19 Reporting and Data System (CO-RADS) and CT Severity Score: A Prospective, Multicenter, Observational Study. Chest. 2020; 159(3):1126-1135. PMC: 7704067. DOI: 10.1016/j.chest.2020.11.026. View

18.

Sudre C, Murray B, Varsavsky T, Graham M, Penfold R, Bowyer R . Attributes and predictors of long COVID. Nat Med. 2021; 27(4):626-631. PMC: 7611399. DOI: 10.1038/s41591-021-01292-y. View

19.

Grasselli G, Greco M, Zanella A, Albano G, Antonelli M, Bellani G . Risk Factors Associated With Mortality Among Patients With COVID-19 in Intensive Care Units in Lombardy, Italy. JAMA Intern Med. 2020; 180(10):1345-1355. PMC: 7364371. DOI: 10.1001/jamainternmed.2020.3539. View

20.

Horwitz L, Jones S, Cerfolio R, Francois F, Greco J, Rudy B . Trends in COVID-19 Risk-Adjusted Mortality Rates. J Hosp Med. 2020; 16(2):90-92. DOI: 10.12788/jhm.3552. View